1. Efficacy of Xpert MTB/RIF Assay in the Diagnosis of Smear Negative HIV Seropositive Pulmonary Tuberculosis Patients
- Author
-
Neerja Jindal, Vishal Sharma, Shilpa Arora, R. K. Bansal, and Reetika Bansal
- Subjects
medicine.medical_specialty ,Tuberculosis ,business.industry ,Hiv seropositive ,Direct microscopy ,Human immunodeficiency virus (HIV) ,Rifampicin resistance ,bacterial infections and mycoses ,medicine.disease_cause ,medicine.disease ,Pulmonary tuberculosis ,Internal medicine ,General Earth and Planetary Sciences ,Medicine ,Sputum ,Smear negative ,medicine.symptom ,business ,General Environmental Science - Abstract
Background: Tuberculosis (TB) is the most common presenting illness and leading cause of death among people living with HIV(PLHIV). Diagnosis of TB among PLHIV is challenging as false negative results are common with direct microscopy (DM) and culture takes long time. WHO (2013) recommended Xpert MTB/RIF assay as an initial test for diagnosis of TB in PLHIV. Methods: The present study was conducted on 142 HIV seropositive patients who were clinically suspected to have TB. The sputum specimens obtained from these patients were divided into two parts; one was processed by DM and the other was used for Xpert MTB/RIF assay. Result: Of the 142 HIV seropositive patients, 90(63.3%) were in the age group of 15-40 years and majority 91(64.08%) were males. Out of 142 sputum specimens collected from these patients, only 5(3.52%) were positive by DM and 31(21.83%) by Xpert MTB/RIF assay. Statistically the difference between the two was significant (p value
- Published
- 2019